iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Glaxosmithkline Pharmaceuticals consolidated net profit declines 1.49% in the June 2022 quarter

26 Jul 2022 , 11:37 AM

Net profit of Glaxosmithkline Pharmaceuticals declined 1.49% to Rs 119.28 crore in the quarter ended June 2022 as against Rs 121.08 crore during the previous quarter ended June 2021. Sales rose 3.72% to Rs 745.10 crore in the quarter ended June 2022 as against Rs 718.37 crore during the previous quarter ended June 2021.

Particulars Quarter Ended
? Jun. 2022 Jun. 2021 % Var.
Sales 745.10 718.37 4
OPM % 19.99 18.48
PBDT 178.90 177.46 1
PBT 163.08 159.92 2
NP 119.28 121.08 -1

Powered by Capital Market – Live News

Related Tags

  • capital market
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.